Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 213782, 11 pages
http://dx.doi.org/10.1155/2014/213782
Research Article

Molecular Mechanism of Yisui Shengxue Granule, a Complex Chinese Medicine, on Thalassemia Patients Suffering from Hemolysis and Anemia of Erythrocytes

1Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
2303 Hospital of Chinese People’s Liberation Army (PLA), Nanning 530000, China
3The Capital Medical University, Beijing 100069, China

Received 22 August 2014; Revised 19 November 2014; Accepted 19 November 2014; Published 10 December 2014

Academic Editor: Yuping Tang

Copyright © 2014 Na-Li Chu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Al-Khabori, S. Bhandari, M. Al-Huneini, K. Al-Farsi, V. Panjwani, and S. Daar, “Side effects of deferasirox iron chelation in patients with beta thalassemia major or intermedia,” Oman Medical Journal, vol. 28, no. 2, pp. 121–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Schrier, E. Rachmilewitz, and N. Mohandas, “Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: Implication for differences in clinical manifestations,” Blood, vol. 74, no. 6, pp. 2194–2202, 1989. View at Google Scholar · View at Scopus
  3. M. D. Scott, P. Rouyer-Fessard, M. Soda Ba, B. H. Lubin, and Y. Beuzard, “α- and β-haemoglobin chain induced changes in normal erythrocyte deformability: cComparison to β thalassaemia intermedia and Hb H disease,” British Journal of Haematology, vol. 80, no. 4, pp. 519–526, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. W. J. Wang, Z. K. Wu, X. H. Zhang et al., “Investigation of survival situation of 197 thalassemic cases treated with Bushen Yisui method,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 15, no. 3, pp. 21–22, 2008. View at Google Scholar
  5. Z.-K. Wu, Y.-M. Liu, X.-H. Zhang et al., “Treatment of β-thalassemia with Bushen Yisui therapy: a randomized controlled trial,” Journal of Chinese Integrative Medicine, vol. 5, no. 2, pp. 137–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Z.-K. Wu, X.-H. Zhang, and M. Li, “Clinical observation on effects of Yisui Shengxue Granule in treating 156 patients with β-thalassemia,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 4, pp. 352–354, 2006. View at Google Scholar · View at Scopus
  7. W. J. Wang, Z. K. Wu, X. H. Zhang et al., “Clinical observation of Yisui Shengxue Granule in treating 25 patients with hemoglobin H disease,” Journal of Chinese Integrative Medicine, vol. 6, no. 2, pp. 153–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. N. Zhang, Criteria for Diagnosis and Therapeutic Effect on Hematopathy, Science Press, Beijing, China, 2007.
  9. W. J. Wang, Z. K. Wu, X. H. Zhang et al., “Effect of Yisui Shengxue Granule on the oxidative damage of erythrocytes from patients with hemoglobin H disease,” Chinese Journal of Integrative Medicine, vol. 18, no. 9, pp. 670–675, 2012. View at Publisher · View at Google Scholar
  10. E. A. Rachmilewitz and P. J. Giardina, “How I treat thalassemia,” Blood, vol. 118, no. 13, pp. 3479–3488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. V. G. Sankaran, T. F. Menne, J. Xu et al., “Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A,” Science, vol. 322, no. 5909, pp. 1839–1842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Cappellini, V. Viprakasit, and A. T. Taher, “An overview of current treatment strategies for β-thalassemia,” Expert Opinion on Orphan Drugs, vol. 2, no. 7, pp. 665–679, 2014. View at Google Scholar
  13. D. Garrick, M. de Gobbi, V. Samara et al., “The role of the polycomb complex in silencing α-globin gene expression in nonerythroid cells,” Blood, vol. 112, no. 9, pp. 3889–3899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Lorincz, D. Schübeler, S. R. Hutchinson, D. R. Dickerson, and M. Groudine, “DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation,” Molecular and Cellular Biology, vol. 22, no. 21, pp. 7572–7580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Chin, M. Singh, V. Banzon et al., “Transcriptional activation of the γ-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms,” Experimental Hematology, vol. 37, no. 10, pp. 1131–1142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. E. Bauer and S. H. Orkin, “Update on fetal hemoglobin gene regulation in hemoglobinopathies,” Current Opinion in Pediatrics, vol. 23, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Lulli, P. Romania, O. Morsilli et al., “MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A,” PLoS ONE, vol. 8, no. 4, Article ID e60436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Rund and E. Rachmilewitz, “β-thalassemia,” The New England Journal of Medicine, vol. 353, no. 11, pp. 1135–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Roussou, N. J. Tsagarakis, D. Kountouras, S. Livadas, and E. Diamanti-Kandarakis, “Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress,” Anemia, vol. 2013, Article ID 617204, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Rund and E. Rachmilewitz, “Medical progress: β-thalassemia,” The New England Journal of Medicine, vol. 353, no. 11, pp. 1135–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Fibach and E. Rachmilewitz, “The role of oxidative stress in hemolytic anemia,” Current Molecular Medicine, vol. 8, no. 7, pp. 609–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Duman, D. Canatan, G. Alanoglu et al., “The antioxidant effects of capparis ovata and deferasirox in patients with thalassemia major,” Journal of Blood Disorders & Transfusion, vol. 4, no. 3, p. 3, 2013. View at Google Scholar
  23. V. Kukongviriyapan, N. Somparn, L. Senggunprai, A. Prawan, U. Kukongviriyapan, and A. Jetsrisuparb, “Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-β thalassemia,” Pediatric Cardiology, vol. 29, no. 1, pp. 130–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Prasartkaew, A. Bunyaratvej, S. Fucharoen, and P. Wasi, “Oxidative stress and antioxidative enzymes in hemoglobin H disease,” Birth Defects Original Article Series, vol. 23, no. 5, pp. 193–198, 1987. View at Google Scholar · View at Scopus
  25. P. Yenchitsomanus and P. Wasi, “Increased erythrocyte superoxide dismutase activities in β 0-thalassaemia/haemoglobin E and in haemoglobin H diseases,” Journal of Clinical Pathology, vol. 36, no. 3, pp. 329–333, 1983. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ong-Ajyooth, K. Suthipark, D. Shumnumsirivath, A. Likidlilid, S. Fucharoen, and P. Pootrakul, “Oxidative stress and antioxidants in β-thalassaemia/haemoglobin E,” Journal of the Medical Association of Thailand, vol. 70, no. 5, pp. 270–274, 1987. View at Google Scholar · View at Scopus
  27. S. Vatanavicharn, M. Anuwatanakulchai, P. Yenchitsomanu et al., “Relationship of serum vitamin E, erythrocyte nonheme iron, and malonyldialdehyde (lipid membrane peroxidation product) in thalassemia,” Birth Defects, vol. 23, no. 5A, pp. 207–211, 1987. View at Google Scholar
  28. E. A. Rachmilewitz, S. B. Shohet, and B. H. Lubin, “Lipid peroxidation in beta-thalassemia major,” Blood, vol. 47, no. 3, pp. 495–505, 1976. View at Google Scholar · View at Scopus
  29. J. Stocks, E. L. Offerman, C. B. Modell, and T. L. Dormandy, “The susceptibility to autoxidation of human red cell lipids in health and disease.,” British Journal of Haematology, vol. 23, no. 6, pp. 713–724, 1972. View at Publisher · View at Google Scholar · View at Scopus
  30. S. L. Schrier and N. Mohandas, “Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties,” Blood, vol. 79, no. 6, pp. 1586–1592, 1992. View at Google Scholar · View at Scopus
  31. E. Shinar and E. A. Rachmilewitz, “Oxidative denaturation of red blood cells in thalassemia,” Seminars in Hematology, vol. 27, no. 1, pp. 70–82, 1990. View at Google Scholar · View at Scopus
  32. J. Cui, Z. L. Zhao, and X. Y. Hong, “Bio-antioxidants with ill therapy,” Journal of Tsinghua University (Science and Technology), vol. 40, no. 6, p. 9, 2000. View at Google Scholar